Jenny Jing Zhang

Representative Matters Pharmaceutical and Life Sciences Patent Litigation

• A group of pharmaceutical companies in Hatch-Waxman litigation against companies seeking approval for generic versions of the commercial product, AVYCAZ®.
• Esperion in Hatch-Waxman litigation against companies seeking approval for generic versions of the commercial products, NEXLITOL® and NEXLIZET®.
• Alkermes in Hatch-Waxman litigation against companies seeking approval for generic versions of the commercial drug product, LYBALVI®.
• A multinational pharmaceutical corporation in appeal of an infringement judgment in litigation brought by Plexxicon.*
• A multinational pharmaceutical corporation in ITC investigation and related district court litigation asserting the pharmaceutical corporation's pre-filled syringe patent against Regeneron's EYLEA® (aflibercept) product.*
• Celltrion in parallel BPCIA patent infringement and inter partes review proceedings involving Celltrion's proposed biosimilar to the oncology drug, Herceptin® (trastuzumab).*
• E. & J. Gallo Winery in defending against patent litigation related to variable rate irrigation technology. Developed claim construction strategy and led briefing that secured favorable Markman decision disposing of key patent claims.*

Trade Secret and Licensing Disputes and Advising

• Insulet Corp. in trade secret misappropriation suit involving the OMNIPOD® insulin patch-pump device, winning preliminary injunction, 9-digit jury verdict and subsequent permanent injunction. Recognized by Law360's "Legal Lions of the Week" and Law.com's "Litigator of the Week Runners-Up." *
• Phreesia in trade secret misappropriation suit involving patient intake software. Secured favorable settlement after fact discovery.*
• Alphonso in trade secret misappropriation suit on smart advertising technology. Successfully argued motion defending adequacy of trade secret disclosures after multiple challenges.*
• A multinational pharmaceutical company in counseling on IP protection strategy for AI-based drug development technology*
• Global pharmaceutical manufacturers in various non-public licensing disputes and international arbitrations.*

Pro bono

• Representation of veterans challenging denial of disability benefits in submitting petitions for rehearing en banc at the Federal Circuit and petitions for writ of certiorari at the Supreme Court. Champagne v. Collins; Steele v. Collins.
• Representation of the Federal Circuit Bar Association as amicus curiae in veterans' benefit cases, co-authoring cert-stage and merits-stage amicus briefs on regulatory and statutory interpretation questions, Veteran Warriors, Inc. v. Secretary of Veterans Affairs (SCOTUS); Bufkin v. McDonough (SCOTUS).*
• Representation of coalition of minority-veterans' organizations as amici curiae challenging the constitutionality of sex-based Selective Service registration requirement, National Coalition for Men v. Selective Service System (SCOTUS).*
• Representation of CATO Institute and Florida Association of Criminal Defense Lawyers as amici curiae challenging the Eleventh Circuit's interpretation of the harmless-error standard in criminal cases, Pon v. United States (SCOTUS).*
• Successfully challenging, on First Amendment grounds, an anti-panhandling ordinance enacted by the City of Lowell, MA on behalf of homeless residents, McLaughlin v. City of Lowell (D. Mass.).*
• Winning a preliminary injunction, on Eighth Amendment and ADA grounds, against a prison's denial of methadone treatment to an inmate recovering from opioid use disorder, Pesce v. Coppinger (D. Mass.).*
• Preparing a trial defense for indigent former healthcare insurance executive facing multiple federal healthcare fraud and identity theft charges, US v. Brettschneider (D. Mass.).*
• Teaching scholarly writing as an adjunct professor at George Washington University Law School.*

*Experience prior to joining White & Case.